徐承富附属第一医院临床医学脂肪性肝病个人简介: 学习经历：2012/10 – 2014/10    美国国立卫生研究院（NIH）                  博士后2010/10 – 2011/03    德国海德堡大学曼海姆医学院                访问学者2005/09 – 2009/06    浙江大学医学院内科学（消化病学）  直博生2000/09 – 2005/08    浙江大学医学院临床医学（七年制）  本科生 工作经历：2017/01 – 至今         浙江大学医学院附属第一医院  消化内科    副主任医师、副研究员、博导2013/07 – 2016/10  浙江大学医学院附属第一医院  消化内科    主治医师、副研究员、博导2013/01 – 2013/06  浙江大学医学院附属第一医院  消化内科    主治医师、副研究员2010/07 – 2012/12  浙江大学医学院附属第一医院  消化内科    主治医师2009/08 – 2010/06  浙江大学医学院附属第一医院  消化内科    住院医师 学术兼职：浙江省肝胆胰肿瘤精准诊治研究重点实验室   副主任中华医学会内科学分会第十四届青年委员会   副主委中国医师协会消化医师分会肝病专业委员会   委  员中华医学会内分泌学分会肝病与代谢学组     委  员中国研究型医院学会肝病专业委员会脂肪肝和酒精肝学组         委员中国老年学和老年医学学会老年病学分会高尿酸与痛风专家委员会 常委 科研项目: 1、课题名称：非酒精性脂肪性肝病课题来源：国家自然科学基金优青项目（81722009）资助年限：2018.01－2020.12资助金额：130万元参加人员：徐承富 2、课题名称：尿酸对肝细胞miR-92a的调节作用及其影响NAFLD的分子机制研究课题来源：国家自然科学基金面上项目（81770573）资助年限：2018.01－2021.12资助金额：50万元参加人员：徐承富 郦圣捷 万星勇 陈祎 李檬 陈盛晖 王景骅 冯泽民 3、课题名称：Olfactomedin 4在非酒精性脂肪性肝病中的作用及机制研究课题来源：国家自然科学基金面上项目（81470838）资助年限：2015.1－2018.12资助金额：73万元参加人员：徐承富 李岚 沈哲 马涵 万星勇 王杰炜 严天连 王玉茗 4、课题名称：黄嘌呤氧化还原酶XOR在非酒精性脂肪性肝病中的作用及机制研究课题来源：国家自然科学基金青年基金（81100278）资助年限：2012.1－2014.12资助金额：23万元参加人员：徐承富 顾竹影 张雪群 沈哲叶桦 吴鸿儒 马涵 周辛欣 5、课题名称：黄嘌呤氧化酶调节非酒精性脂肪性肝病发生发展的分子机制课题来源：浙江省杰出青年科学基金项目（LR15H030001）资助年限：2015.1－2018.12资助金额：30万元参加人员：徐承富 6、课题名称：尿酸干预治疗非酒精性脂肪性肝病的分子机制研究课题来源：2013年度浙江省国际科技合作专项计划项目（2013C24010）资助年限：2013.7－2016.6资助金额：20万元参加人员：徐承富 Ming Yan 杨丽萍 沈哲 张雪群 马涵 万星勇 7、课题名称：microRNA-223在肝脏缺血再灌注损伤中的作用及机制研究课题来源：浙江省自然科学基金（Y2110026）资助年限：2011.1－2013.12资助金额：10万元参加人员：徐承富 张雪群 沈哲 吴鸿儒 叶桦 周辛欣 陈卫星发表论文: 66. Meng Li# Chengfu Xu# Junping Shi# Jiexia Ding Xingyong Wan Dahua Chen Jianguo Gao Chunxiao Li Jie Zhang Yiming Lin Zhenhua Tu Xiaoni Kong Youming Li* Chaohui Yu*. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Gut. 2017 Sep 6. Epub ahead of print65. Xinyu Wang Shenghui Chen Ya-nan Zhang Chengfu Xu*. Olfactomedin-4 in digestive diseases: a mini-review. World J Gastroenterol 2018; 24(17): 1881-1887. (*Corresponding author)64. Jinghua Wang Liang Ma Shenghui Chen Lei Xu Min Miao Chaohui Yu Youming Li Chengfu Xu*. Risk for the development of non-alcoholic fatty liver disease: a prospective study. J Gastroenterol Hepatol 2018;33(8):1518-1523. (*Corresponding author)63. Jinhua Wang# Wanlin Zhu# Shujun Huang Lei Xu Min Miao Chenjiao Wu Chaohui Yu Youming Li Chengfu Xu*. Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: a 7-year prospective study. Liver Int 2017;37(8):1202-1208. (*Corresponding author)62. Jing Liu Chengfu Xu Limei Ying Shufei Zang Zhenjie Zhuang Haifeng Lv Wenjun Yang Yan Luo Xaojie Ma Lei Wang Yunhao Xun  Dewei Ye Junping Shi*. Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults. Hepatol Res 2017; 47(3):E104-E112.61. Yi Chen Haixiu Huang Chengfu Xu Chaohui Yu Youming Li. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis. Int J Mol Sci 2017;18(1). pii: E21. 60. Tianlian Yan Yini Ke Yi Chen Chengfu Xu Chaohui Yu Youming Li. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9 globulin eosinophils and hemoglobin. PLoS One 2017;12(4):e0174735.59. Meng Li# Dahua Chen# Haixiu Huang Jiewei Wang Xingyong Wan Chengfu Xu Chunxiao Li Han Ma Chaohui Yu* Youming Li*. Caveolin1 protects against diet induced hepatic lipid accumulation in mice. PLoS One. 2017;12(6):e0178748.58. Chengfu Xu# Yi Chen# Lei Xu Min Miao Youming Li Chaohui Yu. Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic syndrome features in a Chinese population. Sci Rep 2016; 6:23279.57. Chengfu Xu. Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back. Hepatol Int 2016;10(2):286-293. (*Corresponding author)56. Xingyong Wan# Chengfu Xu# Yiming Lin Chao Lu Dejian Li Jianzhong Sang Haijian He Xiao Liu Youming Li Chaohui Yu. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol 2016;64(4):925-32. (#co-first author)55. Hongzhang Li Liang Ma Jiao’e Chen Wanli Zen Liangmin Jin Xuehua Xu Chengfu Xu* Youming Li. ZJU index is associated with prevalence of Helicobacter pylori infection in a Chinese population. Int J Clin Exp Med 2016; 9(11): 22324-22330. (*Corresponding author)54. Xingyong Wan Chengfu Xu Chaohui Yu Youming Li. Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH. Can J Gastroenterol Hepatol 2016;2016:6489012.53. Fenming Zhang Chengfu Xu Longgui Ning Fengling Hu Guodong Shan Hongtan Chen Ming Yang Wenguo Chen Jiekai Yu Guoqiang Xu*. Exploration of serum proteomic profiling and diagnostic model that differentiate Crohns disease and intestinal tuberculosis. PLoS One 2016; in press.52. Yunfei Feng Chengfu Xu Chaohui Yu Jianguo Shen Youming Li. Thyroid hormone attenuate nonalcoholic fatty liver disease via inducing autophagy in rats. Int J Clin Exp Pathol 2016;9(8):7889-7896.51. Zhenya Lu Han Ma Chengfu Xu Zhou Shao Chao Cen Youming Li*. Serum sialic acid level is significantly associated with nonalcoholic fatty liver disease in a nonobese Chinese population: A cross-sectional study. Biomed Res Int 2016; 2016:5921589. 51、Zhenya Lu Chao Cen Zhou Shao Xinhua Chen Chengfu Xu Youming Li*. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study. World J Gastroenterol 2016;22(5):1884-90.50. Ming Yan Hongsheng Wang Jiafang Sun Wei Liao Peng Li Yin Zhu Chengfu Xu Jungsoo Joo Yan Sun Sadia Abbasi Alexander Kovalchuk Nonghua Lv Warren J. Leonard Herbert C. Morse III. Expression of IRF8 in Gastric Epithelial Cells Confers Protective Innate Immunity against Helicobacter pylori Infection. J Immunol 2016;196(5):1999-2003.49、Zhe Shen Yan Liu Bedair Dewidar Junhao Hu Ogyi Park Teng Feng Chengfu Xu Chaohui Yu Qi Li Christoph Meyer Iryna Ilkavets Alexandra Müller Carolin Stump-Guthier Stefan Munker Roman Liebe Vincent Zimmer Frank Lammert Peter R. Mertens Hai Li Peter ten Dijke Hellmut G. Augustin Jun Li Bin Gao Matthias P. Ebert Steven Dooley Youming Li Hong-Lei Wen. Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression. Am J Pathol 2016;186(7):1874-89.48. Jinghua Wang# Chengfu Xu# Yunhao Xun# Zhenya Lu Junping Shi Chaohui Yu Youming Li. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep 2015; 5:16494. (#co-first author)47. Chao Lu# Chengfu Xu# Xingyong Wan Huatuo Zhu Chaohui Yu Youming Li. Screening for pancreatic cancer in familial high-risk individuals: a systematic review. World J Gastroenterol 2015; 21(28): 8678-8686. (#co-first author)46. Yi Chen Chengfu Xu Tianlian Yan Chaohui Yu Youming Li#. ω-3 Fatty acids reverse lipotoxity through induction of autophagy in nonalcoholic fatty liver disease. Nutrition 2015;31(11-12): 1423-1429.45. Fenming Zhang Chengfu Xu Guodong Shan Hongtan Chen Guoqiang Xu. Is Gallstone disease associated with inflammatory bowel diseases? A meta-analysis. J Dig Dis 2015;16(11):634-41.44. Sreenivasulu Gunti Ronald Messer Chengfu Xu Ming Yan William Coleman Jr. Karin Peterson Kim Hasenkrug Abner Notkins. Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation. Sci Rep 2015;5:15066.43. Xuequn Zhang Yue Pan Chaohui Yu Chengfu Xu Lei Xu Youming Li Weixing Chen. PDIA3 knockdown exacerbates free fatty acid-induced hepatocyte steatosis and apoptosis. PLoS One 2015;10(7):e0133882.42. Xun Xiang Han Ma Yun Mou Chengfu Xu. Association between polymorphism of dopamine D2 receptor genes and therapeutic effect of domperidone in functional dyspepsia. Turk J Gastroenterol 2015;26(1):1-541. Huatuo Zhu Xingyong Wan Jing Li Lu Han Xiaochen Bo Wenguo Chen Chao Lu Zhe Shen Chengfu Xu Lihua Chen Chaohui Yu Guoqiang Xu. Computational Prediction and Validation of BAHD1 as a Novel Molecule for Ulcerative Colitis. Sci Rep 2015;5:12227.40. Chengfu Xu Xingyong Wan Lei Xu Honglei Weng Ming Yan Min Miao Yan Sun Genyun Xu Steven Dooley Youming Li Chaohui Yu. Xanthine oxidase in nonalcoholic fatty liver disease and hyperuricemia: One stone hits two birds. J Hepatol 2015; 62(6):1412-1419.39. Lan Li Guogang Li Chaohui Yu Zhe Shen Chengfu Xu Zhiying Feng Xuequn Zhang Youming Li. A role of microRNA-370 in hepatic ischaemia-reperfusion injury by targeting transforming growth factor-β receptor II. Liver Int 2015; 35(4):1124-1132.38. Chengfu Xu Ming Yan Yan Sun Jungsoo Joo Xingyong Wan Chaohui Yu Qunyan Wang Chao Shen Peng Chen Youming Li William G. Coleman Jr. Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population. Helicobacter 2014; 19(6):437-42.37. Juanwen Zhang# Chengfu Xu# Ying Zhao Yu Chen. The significance of serum xanthine oxidoreductase in patients with nonalcoholic fatty liver disease. Clin Lab 2014;60(8):1301-7. (#co-first author)36. Ping Xu# Chengfu Xu# Xingyong Wan Chaohui Yu Chao Shen Peng Chen Genyun Xu Youming Li. Association between serum alpha-fetoprotein levels and fatty liver disease: a large cross-sectional study from China. World J Gastroenterol 2014; 20(33):11865-11870. (#co-first author)35. Juanwen Zhang Ying Zhao Chengfu Xu Yani Hong Huanle Lu Jianping Wu Yu Chen. Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. Sci Rep 2014;4:5832.34. Guoqiang Xu Chengfu Xu Hongtan Chen Shan Liu Xiaodong Teng Genyun Xu Chaohui Yu. Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice. World J Gastroenterol 2014; 20(28): 9513-9518.33. Chao Shen XiaoliangWu Chengfu Xu Chaohui Yu Peng Chen Youming Li. Association of cholecystectomy with metabolic syndrome in a Chinese population. PLoS One 2014; 9(2): e88189.32. Xuequn Zhang Chengfu Xu Chaohui Yu Weixing Chen Youming Li. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(7):1768-1776.31. Ya-nan Zhang Chengfu Xu Lei Xu Chaohui Yu Min Miao Jianhong Xie Youming Li. High serum ferritin levels increase risk of hyperuricemia: a cross-sectional and longitudinal study. Ann Nutr Metab 2014; 64(1):6-12.30. Wenli Liu Ming Yan Janyce A. Sugui Hongzhen Li Chengfu Xu Jungsoo Joo Kyung J. Kwon-Chung William G. Coleman Griffin P. Rodgers. Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease. J Clin Invest 2013; 123(9): 3751-3755.29. Chengfu Xu Chaohui Yu Han Ma Lei Xu Min Miao Youming Li. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai study. Am J Gastroenterol 2013; 108(8):1299-1304.28. Yan Liu Christoph Meyer Chengfu Xu Honglei Weng Peter ten Dijke Steven Dooley. Animal models for chronic liver diseases. Am J Physiol-Gastrointest Liver Physiol 2013; 304(5):G449-68.27. Han Ma# Chengfu Xu# Lei Xu Chaohui Yu Min Miao Youming Li. Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population. BMC Gastroenterol. 2013;13:3. (#co-first author)26. Hua Ye Chaohui Yu Lan Li Chengfu Xu Xuequn Zhang Youming Li. Meta-analysis of human colorectal cancer transcriptome. Int J Colorectal Dis. 2012;27(8):1125-8.25. Guoqiang Xu Hongtan Chen Chengfu Xu Xiaodong Teng. Esophageal granular cell tumors: report of 9 cases and a literature review. World J Gastroenterol. 2012;18(47):7118-21.24. Lei Xu# Chengfu Xu# Chaohui Yu Min Miao Xuequn Zhang Zongwei Zhu Xiaoyun Ding Youming Li. Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study. PLoS One. 2012;7(8):e44136. (#co-first author)23. Yijun Wu Qi Li Xinhui Zhou Jiren Yu Yunchuan Mu Stefan Munker Chengfu Xu Zhe Shen Roman Müllenbach Yan Liu Li Li Norbert Gretz Derek Zieker Jun Li Kouichi Matsuzaki Youming Li Steven Dooley Honglei WengDecreased levels of active SMAD2 correlate with poor prognosis in gastric cancer. PLoS One. 2012;7(4):e35684.22. Chaohui Yu# Chengfu Xu# Lei Xu Jiekai Yu Min Miao Youming Li. Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease. J Hepatol. 2012; 56(1):241-7. (#co-first author)21. Ning Zhou Weixing Chen Shaohua Chen Chengfu Xu Youming Li. Inflammatory bowel disease unclassified. J Zhejiang Univ Sci B. 2011;12(4):280-6.20. Chengfu Xu Lei Xu Chaohui Yu Min Miao Youming Li. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin Endocrinol. 2011;75(2):240-6.19. Chengfu Xu Chaohui Yu Lei Xu Min Miao Youming Li. High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PLoS One. 2010;5(7):e11578.18. Xinxin Zhou Feng Ji Jingli Zhao Linfang Cheng Chengfu Xu. Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells. J Gastroenterol Hepatol. 2010;25(7):1266-75.17. Xuequn Zhang Juntao Yang Yuanbiao Guo Hua Ye Chaohui Yu Chengfu Xu Lei Xu Songfeng Wu Wei Sun Hangdong Wei Xue Gao Yunping Zhu Xiaohong Qian Ying Jiang Youming Li Fuchu He. Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis. Hepatology. 2010;51(4):1190-9.16. Zhe Shen Youming Li Chaohui Yu Yi Shen Lei Xu Chengfu Xu Genyun Xu. A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels. Eur J Gastroenterol Hepatol. 2010;22(7):820-5.15. Chaohui Yu# Chengfu Xu# Hua Ye Lan Li Youming Li. Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trials. World J Gastroenterol. 2010;16(19):2435-9. (#co-first author)14. Lihua Chen Wenguo Chen Haiiun Cao Hong Zhang Guodong Shan Lin Li Bingling Zhang Chengfu Xu Kaili Ding Ying Fang Ying Cheng Chenjiao Wu and Guoqiang Xu.Double-balloon enteroscopy for obscure gastrointestinal bleeding: a single center experience in China. World J Gastroenterol. 2010;16(13):1655-9.13. Chengfu Xu Chaohui Yu Lei Xu Xiaoying Sa Youming Li. Hypouricemic therapy: a novel potential therapeutic option for nonalcoholic fatty liver disease. Hepatology. 2010;52(5):1865-6. (Letter)12. Chengfu Xu Chaohui Yu Lei Xu Min Miao Youming Li. Is cigarette smoking an independent risk factor or a cofactor for nonalcoholic fatty liver disease? Hepatology. 2010;52(2):803-4. (Letter)11. Lei Xu Chengfu Xu Chaohui Yu Min Miao Youming Li. Haemoglobin and non-alcoholic fatty liver disease: further evidence from a population-based study. Gut. 2009;58(12):1706-7. (Letter)10. Chengfu Xu Chaohui Yu Youming Li. Regulation of hepatic microRNA expression in response to ischemic preconditioning following ischemia/reperfusion injury in mice. OMICS. 2009;13(6):513-20.9. Chaohui Yu# Chengfu Xu# Youming Li. Association of MicroRNA-223 expression with hepatic ischemia/reperfusion injury in mice. Dig Dis Sci. 2009;54(11):2362-6. (#co-first author)8. Feng Ji Yuemei Xu Chengfu Xu. Endoscopic polypectomy: a promising therapeutic choice for esophageal carcinosarcoma. World J Gastroenterol. 2009;15(27):3448-50.7. Youming Li Chengfu Xu Chaohui Yu Lei Xu Min Miao. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol. 2009;50(5):1029-34.6. Chengfu Xu Xuequn Zhang Chaohui Yu Guohua Lu Shaohua Chen Liming Xu Wei Ding Qiaojuan Shi Youming Li. Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5β. Proteomics 2009; 9(2):409-419.5. Chengfu Xu Chaohui Yu Youming Li. Ischaemia-reperfusion injury in non-alcoholic steatohepatitis (NASH) liver: a tough problem to cope with. Gut. 2008;57(11):1631. (Letter)4. Youming Li Lan Li Chaohui Yu Youshi Liu Chengfu Xu. A systematic review and meta-analysis of the treatment for Barretts esophagus. Dig Dis Sci. 2008 ;53(11):2837-463. Chengfu Xu Chaohui Yu Youming Li. Current studies on therapeutic approaches for ischemia/reperfusion injury in steatotic livers. Hepatol Res. 2008;38(9):851-9.2. Zhe Shen Youming Li Chaohui Yu Yi Shen Lei Xu Chengfu Xu Jinjin Chen Hua Ye Genyun Xu. Risk factors for alcohol-related liver injury in the island population of China: a population-based case-control study. World J Gastroenterol. 2008;14(14):2255-61.1. Chengfu Xu Chaohui Yu Youming Li Lei Xu Juan Du Zhe Shen. Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease. World J Gastroenterol. 2007;13(33):4504-8.成果奖励:1、项目名称：长爪沙鼠非酒精性脂肪肝病模型（高脂血症模型）的建立及其遗传学的研究奖励名称：2016年中国实验动物学会科学技术奖三等奖。获奖人员：刘月环，吴旧生，应华忠，徐承富，石巧娟，余陈欢2、项目名称：非酒精性脂肪性肝病发病机制与诊治的研究奖励名称：2015年度高等学校科学研究优秀成果奖(科学技术)一等奖获奖人员：虞朝辉 厉有名 徐承富 张雪群 郑敏，郦圣捷 金希 沈哲 陈卫星 陈韶华 徐磊 王兰 徐萍.3、项目名称：非酒精性脂肪性肝病发病机制与诊治的研究奖励名称：2012年浙江省医药卫生科技创新一等奖获奖人员：厉有名 徐承富 虞朝辉 张雪群 郦圣捷 金希 沈哲 陈卫星 陈韶华 徐磊王兰 徐萍 姜玲玲 刘江 金杭斌 缪敏 吴鸿儒 杜娟.4、项目名称：生物芯片技术在消化系统疾病中的应用基础和临床研究奖励名称：2010年浙江省科学技术奖二等奖获奖人员：厉有名 陈韶华 虞朝辉 李岚 郦圣捷 徐承富 章宏 金希 张雪群 陈春晓陈卫星 张幸国5、项目名称：肝脏脂肪变性对缺血再灌注损伤和预处理保护作用的影响奖励名称：2009年浙江省科学技术奖二等奖(0902096)获奖人员：厉有名 徐承富 陈韶华 沈哲 徐磊 徐黎明 孔梅 石巧娟 张雪群 虞朝辉